BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, May 7, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

Chronic fatigue syndrome framed as hypometabolic disorder

Sep. 2, 2016
By Anette Breindl
A metabolomics signature consisting of a group of eight metabolites in males and 13 metabolites in females was able to diagnose myalgic encephalomyelitis/chronic fatigue syndrome (CFS) with better than 90 percent accuracy, possibly enabling more accurate diagnosis of a disorder that remains hard to pin down.
Read More

Beige fat cells stay the course through autophagy inhibition

Aug. 30, 2016
By Anette Breindl
Energy-burning brown fat cells have generated much heat as a possible weapon in the fight against obesity.
Read More

Bench Press: BioWorld looks at translational medicine

Aug. 29, 2016
By Anette Breindl
Separating delta opioid receptors from the G protein-coupled receptor kinase 2 (GRK2), which normally associates with it in cell membranes, allowed agonists to have an analgesic effect via the delta receptor.
Read More

In lungs, T cells err on side of caution in fighting tumor cells

Aug. 26, 2016
By Anette Breindl
The lungs are a frequent site of metastases in part because T cells sense oxygen levels and are more tolerant of foreign antigens in high-oxygen environments, scientists reported in the Aug. 25, 2016, advance online issue of Cell.
Read More

Anticoagulant target avoids bloody tradeoff

Aug. 25, 2016
By Anette Breindl
Targeting the intrinsic clotting pathway may offer a way to reduce the risk of clotting without increasing bleeding risk, which is the tradeoff of all currently marketed antithrombotics.
Read More

Bench Press: BioWorld looks at translational medicine

Aug. 22, 2016
By Anette Breindl
Edible nanoparticles made from ginger reduced pro-inflammatory cytokines, increased anti-inflammatory cytokines, reduced acute colitis, enhanced intestinal repair and prevented chronic colitis and colitis-associated cancer in mouse models of Crohn's disease and ulcerative colitis, which together make up inflammatory bowel disease (IBD).
Read More

New, cleaner opioid offers hope for fewer side effects

Aug. 22, 2016
By Anette Breindl
Chronic pain is an enormous problem, affecting about 10 to 15 percent of the adult population. Another enormous problem? Opioid painkiller addiction, which kills about 30,000 Americans annually.
Read More

Using delivery vehicle for trash pickup could dampen autoimmunity

Aug. 19, 2016
By Anette Breindl

Using delivery vehicle for trash pickup can dampen autoimmunity

Aug. 19, 2016
By Anette Breindl
Dendrimers are highly branched nanoparticles that are being explored in a variety of biomedical settings. They have been tested clinically to deliver chemotherapy and imaging agents, and are being tested preclinically with payloads that include small molecules and nucleic acids. (See BioWorld Today, March 18, 2009, and May 11, 2011.)
Read More

Genetic homogeneity in sequenced individuals can lead to health disparities

Aug. 18, 2016
By Anette Breindl
As the Exome Aggregation Consortium (Exac) published findings from their deep dive into the genetic well Wednesday, another set of scientists published a cautionary tale illustrating the sort of clinical problem that Exac's Exome Sequencing Project (ESP) can address. (See story in this issue.)
Read More
Previous 1 2 … 165 166 167 168 169 170 171 172 173 … 401 402 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 6, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • Regulatory actions for May 5, 2026

    BioWorld
    Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing